Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957736 · ClinicalTrials.gov registry record
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
A clinical trial, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- 252
- Enrollment target
NCT00957736: Clinical Trial study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00957736 is a clinical trial that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 252 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00957736 was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- 252 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to chronic graft-versus-host disease in patients who have undergone donor stem cell transplant. PURPOSE: This phase I trial is studying chronic graft-versus-host disease in patients who have undergone donor stem cell transplant.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
Why NCT00957736 stopped before completion
NCT00957736 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00957736 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00957736 about?
NCT00957736 is a clinical study titled "Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant". RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to chronic graft-versus-host disease in patients who have undergone donor stem cell transplant. PURPOSE: This phase I trial i...
What is the current status of trial NCT00957736?
This trial is currently terminated. The enrollment target is 252 participants. The study started on 2008-11. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00957736?
The interventions under investigation include: laboratory biomarker analysis (OTHER), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT00957736?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia